Ignite Creation Date:
2024-05-05 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00308581
Status:
COMPLETED
Last Update Posted:
2018-08-07
First Post:
2006-03-28
Brief Title:
Certolizumab in Crohns Disease Patients With Loss of Response or Intolerance to Infliximab
Sponsor:
UCB Pharma
Organization:
UCB Pharma